This term refers to a condition that disrupts a person’s metabolism. Morquio syndrome is a form of mucopolysaccharidoses (MPS). These conditions affect the enzymes that the body uses to break ...

and based on the experience with ERT in other mucopolysaccharidoses. In conclusion, the results of this study suggest a favorable benefit/risk profile for elosulfase alfa in pediatric Morquio A ...

The drug, Vimizim, is being developed by BioMarin Pharmaceutical Inc to treat Morquio A Syndrome, one of a group of lysosomal storage disorders known as mucopolysaccharidoses (MPS). Morquio A ...

Morquio A Syndrome is one of a group of lysosomal storage disorders known as mucopolysaccharidoses (MPS). Lysosomal storage disorders are typically chronic and progressive, and involve multiple ...

Nov 19 (Reuters) - An experimental drug to treat Morquio A Syndrome, a rare genetic disorder that causes skeletal malformation and a variety of related lung, eye, ear and heart problems ...